Head-to-Head Analysis: Bio Marrone Innovations (MBII) versus Evogen (EVGN)

Business



[ad_1]

Marrone Bio Innovations (NASDAQ: MBII) and Evogene (NASDAQ: EVGN) are two small-cap core materials companies, but what is the best investment? We will compare the two companies based on the strength of their risks, dividends, valuation, profitability, institutional ownership, earnings and badyst recommendations.

Profitability

This table compares Marrone Bio Innovations and Evogene Net Margins, Return on Equity and Return on Assets

Net Margins Return on Equity Return on Investment Active Agents
Marrone Bio Innovations [19659008] -144.82% N / A -62.44%
Evogen -706.44% -29, 69% -26.71%

Gain and Profit

This table compares Marrone Bio Innovations and the business figure, earnings per share and valuation of Evogene.

Gross income Price / sales ratio Net income Earnings per share Price / earnings ratio
Marrone Bio Innovations $ 18.17 million 10.73 – $ 30.92 million ($ 1.07) -1.79
Evogene $ 3.38 million 22.63 [19659008] – $ 20.83 million [19659009] N / A N / A

Evogene has a lower business figure, but higher profits than Marrone Bio Innovations.

Analyst Estimates

This is a breakdown of current ratings and target prices for Marrone Bio Innovations and Evogene, as reported by MarketBeat.com.

Sales Clbadification Rating Rank Buy Notes Buy It Strong Rating
Marrone Bio Innovations 0 2 [19659008] 1 0 [19659009] 2.33
Evogenes 0 0 0 0 N / A

Marrone Bio Innovations currently has a goal consensus price of $ 2.18, suggesting a potential upside of 14.31%. Given the upside potential of Marrone Bio Innovations, stock badysts believe that Marrone Bio Innovations is more favorable than Evogene

Insider and Institutional Ownership

38.3% of Marrone Bio Innovations shares are held by institutional investors. In comparison, 35.7% of Evogene shares are held by institutional investors. 2.9% of Marrone Bio Innovations shares are held by insiders of the company. Strong institutional ownership indicates that large fund managers, hedge funds and endowments believe that a company will outperform the market in the long run.

Volatility & Risk

Marrone Bio Innovations has a beta of -0.55, which indicates that its actions Comparatively, Evogene has a beta of 0.76, which indicates that its price is 24% less volatile than the S & P 500.

Abstract

Marrone Bio Innovations beats Evogene on 7 the 11 factors compared between the two stocks.

About Marrone Bio Innovations

Marrone Bio Innovations logo "title =" Marrone Bio Innovations logo "clbad =" companylogo "/> Marrone Bio Innovations, Inc. provides bio Phytosanitary and phytosanitary products, mainly for agricultural and water markets in the United States and around the world, with herbicides, fungicides, nematicides, insecticides, algicides for the control of algae, molluscicides for mussels and control of nails, plant growth and stress regulators, and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water , aquaculture, irrigation and recreation.The company's products include Regalia, a biopesticide fungicide-based plant extracts for the control of plant diseases and s anté plants; and Grandevo, a bioinsecticide for the control of insects and mites for specialty crop producers such as grapes, citrus fruits, tomatoes, vegetables, nuts, leafy greens and ornamentals. It also supplies zequanox, a biomolecicide that controls invasive mussels, which cause damage to infrastructure and the environment primarily to energy and industrial companies; and Venerate, a bioinsecticide that controls insects and mites that chew and suck, as well as phytoparasitic flies and nematodes. In addition, the company offers Haven, a sunscreen product that reduces stress and dehydration of plants; and Majestene and Zelto, a bionematicide for controlling soil nematodes by preventing and reducing root galls, as well as reducing adult reproduction and hatching of eggs. In addition, it provides Stargus and Amplitude, a biofungicide to improve plant health. Marrone Bio Innovations, Inc. provides its products directly through the sales force, as well as through distributors. Marrone Bio Innovations, Inc. was founded in 2006 and is headquartered in Davis, California. </p> <p><strong style= About Evogene

Evogene Logo "title =" Evogene Logo "=" companylogo "/> Evogene Ltd., a biotechnology company, focuses on improving the productivity and crop performance in the United States, Germany and internationally, with three segments: Evogene, Evofuel and Biomica.This segment develops seed traits improving plant yield and abiotic stress tolerance. , such as increased tolerance to drought, heat and salinity, as well as seed characteristics for plants, improving plant resistance to biotic stresses, including resistance to diseases, pests and insects, new herbicides and bio-stimulants, and biopesticides including microbial-based products that are applied to the outdoors. s, such as corn, soybeans, wheat, rice and cotton. The Evofuel segment develops improved castor plant species to serve as a source of raw materials for biofuels and other industrial uses. The Biomica segment discovers and develops therapeutics based on human microbiome for the treatment of immune-mediated and infectious diseases. The company has strategic collaborations with various agricultural companies, including BASF, Bayer, DuPont, Monsanto, Dow Chemical, Syngenta, and Insolo Agroindustrial SA Evogene Ltd. was founded in 1999 and is based in Rehovot, Israel. <!--ViewCount:ArticleHistoryID=21331817&PostDate=2018-7-14&type=y&tertiary=1&id=99557--></p> <p> <!-- end inline unit --></p> <p> <!-- end main text --></p> <p> <!-- Invalidate Article --></p> <p> <!-- End Invalidate --></p> <p><!--Begin Footer Opt-In--></p> <p style= for Marrone Bio Innovations Daily – Enter your email address below to receive a concise daily summary of the latest news and badyst ratings for Marrone Bio Innovations and related companies with the free daily newsletter of MarketBeat.com

[ad_2]
Source link

Tags

Powered by https://naaju.com/israel | Designed by Naaju
© Copyright 2024, All Rights Reserved